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ABSTRACT
Fungal infections are still a major problem. Some limitations of current antifungals (toxicity, 
fungal resistance) require the search for new drugs. The interest in metal–sulfanilamide derivatives was 
stimulated by the successful introduction of a silver-sulfadiazine complex, yet in current use, to prevent 
microbial infections during burn treatment of both humans and animals. Sulfadimethoxine (HSDM) is 
used in medicine, most frequently veterinary, to treat many infections, such as respiratory, urinary, etc. In 
this work we report the synthesis, characterization by elemental analysis, FTIR, 1H NMR and 13C NMR 
spectra of the heteroleptic complexes [Ag3SDM(SCN)2]·H2O and [Ag2(SDM)2o-phenanthroline]·H2O, 
named as AgSDM-SCN and AgSDM-phen, respectively, and the biological properties (lipophilicity, 
antifungal, phyto, cyto and genotoxicity) of AgSDM-SCN, AgSDM-phen and the homoleptic one: 
AgSDM. 1H NMR spectra show that the sulfonamide moiety loses its acidic proton in both complexes, in 
agreement with the FTIR results. The three complexes showed a moderate antifungal activity, mainly 
against the yeasts Candida albicans, C. tropicalis and Cryptococcus neoformans. None of the tested fungi 
was inhibited by the free ligand. Lipophilicity: log Koctanol/water values were 0.80, 0.84, 0.85, 0.94 and 0.43 
for HSDM, NaSDM, AgSDM, AgSDM-SCN and AgSDM-phen respectively, similarly to another sulfa-
metal complexes. No genotoxicity or cytotoxicity were observed for AgSDM and AgSDM-SCN in the 
Allium cepa test, different from AgSDM-phen. Given these results, the studied complexes could be good 
candidates for further pharmaceutical studies.
Keywords: sulfadrug metal complex; antifungal properties; lipophilicity, Allium cepa test   
Abbreviations: HSDM: sulfadimethoxine; NaSDM: sulfadimethoxine, sodium salt; AgSDM: complex of Ag(I) 
with sulfadimetoxine;  AgSDM-SCN: complex of Ag(I) with sulfadimetoxine and the thiocyanate  group; AgSDM-
phen: complex of Ag(I) with sulfadimetoxine and o-phenantroline; ATCC: American Type Culture Collection; C: 
CEREMIC (Centro de Referencia en Micología, Facultad de Ciencias Bioquímicas y Farmacéuticas, Suipacha 531 
(2000) Rosario, Argentina); DMSO: dimethylsulfoxide; MIC: minimum inhibitory concentration; MFC: 
minimum fungicidal concentration;  MI: mitotic index; CI:  cytotoxic index = MI of the sample/MI of 
negative control; RL:  root length. 
Highlights
1) Two new silver-sulfadimethoxine complexes were synthesized.
2) Coordination of silver ions occurs through amide and heterocyclic nitrogens.
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Fungal infections are still a big problem. Two new heteroleptic complexes between sodium 
sulfadimethoxine (NaSDM) and the silver(I) ion: AgSDM-SCN and AgSDM-phen, and AgSDM, showed 
moderate antifungal activity (sulfadimethoxine was inactive), low affinity towards animal fatty tissues 
and no geno or cytotoxicity in the Allium cepa test, except AgSDM-phen, so, these complexes could be 
good candidates for further pharmaceutical studies.
1. Introduction
Fungal infections are still a major problem [1] There are several limitations in current antifungals, 
including that some of them displayed high toxicity, while others generate fungal resistance. Therefore, 
there is an urgent need to develop new antifungals [2], and, in a first instance, the evaluation of its cyto 
and genotoxicity with the Allium cepa test might be a good option [3].
Silver is a metal with good antimicrobial properties because of its high toxicity to microorganisms and 
low toxicity to mammalian cells [4]. The interest in metal–sulfanilamide derivatives has grown in recent 
years as a result of the successful introduction of the silver-sulfadiazine complex to prevent bacterial 
infections during burn treatment of both humans and animals, which is still in current use [5].
Sulfadimethoxine (Fig. 1) is a sulfonamide antibiotic employed to treat many infections including 
treatment of respiratory, urinary tract, enteric, and soft tissue infections. It is most frequently used in 
veterinary medicine, although it is approved in some countries for human use [6].
Fig. 1.Sulfadimethoxine (HSDM), IUPAC name: 4-Amino-N-(2,6-dimethoxypyrimidin-4-yl)benzenesulfonamide; 
formula:  C12H14N4O4S, MW: 310.33 g.mol-1
Recently, the crystalline structure of the homoleptic complex of silver with sulfadimethoxine, 
AgSDM, has been determined, both in aqueous [7,8] and organic medium [9]. The antibacterial properties 
[7,8] and DNA interaction [9] of AgSDM were determined, but not its antifungal properties.
As a continuation of our studies on silver complexes [10-12], in this work we report the synthesis 
and characterization of the heteroleptic complexes [Ag3SDM(SCN)2]·H2O and [Ag2(SDM)2o-
phenanthroline]·H2O, named as AgSDM-SCN and AgSDM-phen, respectively, and the biological 
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properties (lipophilicity, antifungal, phyto, cyto and genotoxicity) of AgSDM-SCN, AgSDM-phen and 
the homoleptic one: AgSDM.
2. Material and methods
2.1.  Materials
Sulfadimethoxine, as sodium salt (NaSDM, FNA grade, Parafarm>99%; MW: 332.3 g.mol-1), 
AgNO3 (FNA grade, Parafarm>99%) and all other chemicals of commercially available reagent grade, 
were used as received. 
2.2. Preparative
In general,experiments were performed by mixing solutions of AgNO3 (aq) with NaSDM (aq) and 
the second ligand in a 1:1 or 1:1:1 molar ratio, as appropriate, and according to previously reported 
procedures [10-12]. During all experimental steps, both solutions and precipitates were protected from 
light. Elemental chemical analyses (C, H, N and S) were performed in a microanalyser Carlo Erba 
EA1108 (Carlo Erba Reagents S.A., Italy).
AgSDM: in a typical experience, 2 mL of aqueous solution of silver nitrate containing 0.1872 g (1 mmol + 
approximately 10% excess) were added dropwise to 4 mL of stirring aqueous solution containing 0.332 g 
of NaSDM (1 mmol). Immediately, a white suspension was formed. The mixture was stirred in the 
absence of light for 20 min. Then, it was left to stand at room temperature, away from light. After 24 h, 
the mixture was filtered under vacuum, washed several times with water, and dried in the dark [13].
Elemental analysis [AgSDM]: (AgSDM) white crystals, calculated MW: 417.19 g.mol-1. Anal. Calcd. for 
AgC12H13N4O4S (%): C, 34.5; H, 3.1; N, 13.4; S, 25.9. Experimental (%): C, 34.6; H, 3.2; N, 13.3; S, 
26.2. [12]. Yield: 94 %. These data are consistent with those reported by Dubey et al, 2018 [7] and Fiori 
et al, 2017 [8].
AgSDM-SCN: in a typical experience, 2 mL of aqueous solution of 1.1 mmol of silver nitrate was added 
dropwise to 4 mL of stirring aqueous solution containing 1 mmol of NaSDM.  Immediately, 4 mL of 
aqueous solution of 0.0987 g (1 mmol) of potassium thiocyanate was incorporated to the white 
suspension. After stirring the mixture for 20 min in the absence of light, the white precipitate was filtered 
under vacuum,washed several times with water and dried in the dark at room temperature. 
Elemental analysis: [Ag3SDM(SCN)2]·H2O: (AgSDM-SCN)  white solid, calculated MW: 767.115 
g.mol-1. Anal. Calcd. for Ag3C14H15N6O5S3(%): C, 21.9; H, 2.0; N, 11.0; S,12.5. Experimental (%): C, 
22.9; H, 1.9; N, 11.3; S, 13.0. Yield: 84 %.
AgSDM-phen: This heteroleptic silver complex was synthesized following a similar technique, replacing 
KSCN by o-phenantroline (phen, 0.1802 g: 1 mmol), which was dissolved in 1 mL of ethanol. The 
AgNO3 solution was added dropwise to the NaSDM solution. A white precipitate was obtained, onto 
which the phen solution was added dropwise under stirring, obtaining a whitish precipitate. A few mL of 
distilled water was added in order to resuspend the precipitate, which was left to rest for 2 hours, 
protected from light. After this time, it was filtered under vacuum, washed three times with water and two 
times with ethanol. The obtained whitish solid was allowed to dry on the same filter, in the air and 
protected from light. 
Elemental analysis: [Ag2(SDM)2phen]·H2O: (AgSDM-phen) whitish solid, calculated MW: 1032.611 
g.mol-1. Anal. Calcd. for  Ag2C36H36N10O9S2 (%): C, 41.9; H, 3.5; N, 13.6; S, 6.2. Experimental (%): C, 




IR spectra of powdered samples were measured with a Bruker IFS 66 FTIR-spectrophotometer 
(Billerica, MA, USA) from 4000 to 400 cm-1, using the KBr pellet technique. 1H NMR and 13C NMR 
spectra in deuterated dimethylsulfoxide (DMSO-d6) were obtained using a Bruker AC-300 E 
spectrometer at ambient probe temperature (ca. 25ºC), with nominal operating frequencies of 300.1 and 
50.3 MHz, respectively.
All chemical shifts (δ) are quoted in parts per million (ppm). Chemical shifts (δ) are in ppm 
relative to the residual DMSO-d6 signals (2.50 and 39.48ppm for 1H and 13C, respectively). Positive 
values of chemical shifts denote high frequency shifts (less shielded) with respect to standards. 
2.4. Lipophilicity test
Lipophilicity tests for NaSDM and the three silver complexes were performed in order to 
determine the partition coefficient between n-octanol and water [11]. The concentration of the compound 
in the original aqueous solutions and after contact with n-octanol was determined spectrophotometrically 
at 268-269nm. UV-Vis spectra of the complexes are presented in Supplementary material, Fig. S1 (A-C).
2.5. Antifungal assays
The microorganisms used for assessing antifungal properties were purchased from ATCC, or were 
clinical isolates from CEREMIC (identified with C). Yeasts: Candida albicans ATCC 10231, C. 
tropicalis CCC131, Saccharomyces cerevisiae ATCC 9763, Cryptococcus neoformans ATCC 32264. 
Hialohyphomycetes: Aspergillus fumigatus ATCC 26934, A. flavus ATCC 9170, A. niger  ATCC 9029. 
Dermatophytes: Microsporum gypseum C 115, Trichophyton rubrum C 113, T. mentagrophytes ATCC 
9972. The fungal strains were grown on Sabouraud-chloramphenicol agar slants for 48 h at 30ºC. The 
strains were maintained on slopes of Sabouraud-dextrose agar (SDA, Oxoid) and subcultured every 15 
days to prevent pleomorphic transformations. Spore suspensions were obtained according to reported 
procedures [14] and adjusted to 1103 spores with colony forming ability/mL. Assay: Minimum 
Inhibitory Concentration (MIC) of each compound was determined by using broth microdilution 
techniques according to the guidelines of the Clinical and Laboratory Standards Institute (CLSI 2008, 
formerly National Committee for Clinical Laboratory Standards NCCLS) for yeasts (M27-A3) and for 
filamentous fungi (M38-A2). MIC values were determined in RPMI-1640 (Sigma-Aldrich, St Louis, MO, 
USA) buffered to pH 7.0 with MOPS. Microtiter trays were incubated at 35°C for yeasts and 
hialohyphomycetes and at 28-30°C for dermatophyte strains in a moist, dark chamber. For the assay, 
stock solutions of pure compounds were two-fold diluted with RPMI from 250 to 0.98 g.mL-1 (final 
volume = 100 L) and a final DMSO concentration ≤ 1%. A volume of 100 L of inoculum suspension 
was added to each well with the exception of the sterility control where sterile water was added to the 
well instead. 
Endpoints (MIC) were defined as the lowest concentration of drug resulting in total inhibition of 
visual growth compared to the growth in the control wells containing no antifungal. They were recorded 
at 48 h for yeasts (as an example, a photograph of these wells for AgNO3 and AgSDM is presented in 
Supplementary material, Fig. S2), and at a time according to the control fungus growth, for the rest of 
fungi.The minimum fungicidal concentration (MFC) was determined by plating by duplicate 5 mL from 
each clear well of MIC determinations onto a 150 mm SDA plate. After 48 h at 37°C, MFCs were 
determined as the lowest concentration of each compound showing no growth in the plates. Both MIC 
and MFC were confirmed by two replicates. Despite the specialized international recommendations [15] 
a variety of breakpoints is observed in the literature [16], so we decided to take the value of 250 μg/mL 
as cut-off point for MICs [11,12,17] against all the analyzed fungi: MICs ≤ 250 µg.mL-1 were considered 
active. Amphotericin B (Janssen Pharmaceutica, Beerse, Belgium), Ketoconazole (Sigma-Aldrich, St 
Louis, MO, USA) and Terbinafine (Novartis, Bs. As., Argentina) were used as positive controls. 
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2.6. Plant Genotoxicity Test (Allium cepa Test)
For this test, which was performed by following standard procedures [18], equal-sized young 
bulbs of common Allium cepa L. were used. Considering the antifungal MIC values, the experiments 
covered a 0.250–0.012 g.L-1 sulfonamide complex range. Selected yellow onion bulbs were exposed to 
increasing concentrations of the tested substances (the complexes and the ligands, 7 bulbs/dose). Mother 
solution (0.250g.L-1) and its dilutions (3/4, 1/2, 1/4 and 1/20) were analyzed. In a typical experience, an 
amount close to 0.125 g of AgSDM was exactly weighed. This quantity was dissolved in 10 mL of 
DMSO, completing to 500.0 mL with mineral water. Stock solutions of the ligands (NaSDM, phen) and 
the other silver complexes were prepared in a similar way. Aliquots from these mother solutions were 
taken out, in order to carry out the experiments. The noninterference of AgNO3 (in distilled water instead 
of mineral water) and DMSO (until 2.5 % V/V, Fig S3) were checked by dose–response curves. The 
silver(I) ion concentration released from the complexes was not sufficient for precipitation of AgCl into 
the mineral water in which the onions were grown. Onion bulbs were kept in mineral water for 48 h, then 
exposed to the silver complexes and ligand solutions for 24 h, and next, the onions were placed into 
mineral water for 24 h (recovery time). The roots were then fixed in 1:3 acetic acid/ethanol solution for 
24 h and finally stored in 70% ethanol. The roots growing in mineral water were used as a negative 
control, while the treatment with K2Cr2O7 (1–5 mg.L-1 in mineral water) represented a positive control. 
The length of the roots as an index of toxicity and modifications in root consistency and shape (formation 
of tumors, hookroots, twisted roots) were observed as macroscopic parameters. We follow the technique 
of measuring the longest root per bulb, already used in previous experiences [11]. The microscopic 
parameter was the mitotic index (MI). For the MI we evaluated al least five slides, 1000 cells per slide, as 
sum of meta, ana and telophases to evaluate cellular division rate. For the chromosomes preparation and 
staining, root tips were hydrolyzed in 6 mol.L-1HCl at room temperature (25ºC, 10 min) before staining in 
Schiff’s reagent (from Sigma-Aldrich): pararosaniline 1%, sodium metabisulfite 4%, in HCl 0.25M) for 
15 min. After the root caps were removed from well stained root tips, 1 mm of the meristematic zones 
was immersed in a drop of 2% orcein in 45% acetic acid (which carried out the staining of the 
chromosomes) on a clean slide and squashed into single cells. A Globelight microscope was used with 
640 magnification for observations. Photographs of selected preparations were taken with an 
OLYMPUS BX40 optical microscope coupled to a digital camera (Olympus D-560 Zoom,Tokyo, Japan).
Statistical analysis: One-way analysis of variance (ANOVA) was applied, followed by post hoc 
comparisons with the Student's t-test to estimate the significance of the differences between groups. 
Scatter plots were used to study at first the relationship between the variables, and linear regression to 
describe it [19]. Data were expressed as mean ± standard deviation (SD). A p<0.05 was considered of 
statistical significance [20].
3. Results and discussion
3.1. Vibrational Fourier transformed infrared spectra
Fourier transformed infrared spectra (FTIR) of HSDM, NaSDM and its heteroleptic silver 
complexes, AgSDM–SCN and AgSDM–phen, are shown in Fig. 2. The FTIR spectrum of the homoleptic 
complex AgSDM was included for comparison. The assignments of the main vibrational FTIR 
frequencies are shown in Table 1. In order to obtain a wider insight on the coordination of the metal to 
the ligand, the experimental infrared spectrum of AgSDM was assigned by comparison with the 
protonated ligand (HSDM) and its sodium salt. The analysis was performed taking into account previous 
papers concerning HSDM coordination complexes [21,22] and general articles and books in order to 
avoid discrepancies in literature [23-27].
: 
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Table 1.Assignment of the vibrational FTIR spectra (wavenumbers, cm-1) of sulfadimethoxine (HSDM), 
its sodium salt (NaSDM) and its Ag(I) complexes
HSDM NaSDM AgSDM AgSDM-SCN AgSDM-phen Assignments
3405 m 3526 w, 3490 w, 
3438 w










3235 s  (NH)(sulfonamide)
3225 w, 3134 w 3251 w 3233 w 3233 w
3011 w 2998 w 3001 w 2953 w 2949 w asCH3
2949 w 2948 w 2950 w 2938 w 2930 w sCH3
2086 m C-N,  SCN
1646 sh 1639 sh 1647 sh 1627 sh 1630 sh δ(NH2)
1595 vs 1602 vs 1593 vs 1596 vs 1596 vs δ(NH2),
 (C=C)
1549 s 1544 s 1544 m 1540 m  (C=C), νas(C=N)-aromatic 
rings
1446 m 1435 s 1439 s 1441 m 1434 m νs(C=N)-pyrimidine ring






1359 vs 1354 vs 1354 vs asSO2
1279 sh
1198 vs
1287 sh, 1247 sh, 
1211 vs
1307 w, 1248 
s, 1205 s
1304 w, 1270 w, 
1220 s, 1201 sh
1311 w, 1263 
sh, 1216 s
CO, CO-aromatic ring
1145 vs 1131 vs 1131 vs 1130 s 1130 s sSO2
1103 s, 
1095 s
1085 m, 1069 m 1082 m, 1073 
m
1092 m, 1083 m 1083 m ip NH
987, 974 w 983 w 989 w 983 w 988 w ν(S–N-), CO, CO-CH3
841 m, 721 m δ(CH) o-phen
754 w C-S
471 w (NCS)
Band description: s, strong; m, medium; w, weak; vw, very weak; br, broad; sh, shoulder. FTIR: Fourier transform infrared. 
AgSDM: [Ag(SDM)]; AgSDM-SCN: [Ag3SDM(SCN)2]·H2O; AgSDM-phen: [Ag2(SDM)2phen]·H2O
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Fig.2. FTIR spectra of sulfadimethoxine (HSDM), its sodium salt (NaSDM) and its Ag(I) complexes (AgSDM, 
AgSDM–SCN and AgSDM–phen) in the wavenumber range of 4000-400 cm-1
As shown in Table 1, the NH stretching of HSDM corresponds to the very strong band located at 
3235 cm-1 and it is absent in the complexes and in the sodium salt, indicating the presence of the 
deprotonated ligand in both cases. In addition, the strong band at 1095 cm-1 assigned to the in plane 
stretching NH mode, appeared with low intensities in the complexes.
In spite that in the ca. 1600 cm-1 region the intensities of the bands are very strong, the band at 1595 cm-1 
of HSDM is the most intense band of the compounds (Fig.2). Upon coordination or deprotonation, the 
intensity of this band is weakened, and new strong bands appeared at ca. 1550 cm-1. These bands could be 
ascribed as vibrations involving the aromatic rings (C=C and C=N groups).
The strong bands related to stretchings of the SO2 group remained unchanged upon deprotonation 
or coordination. This fact is a demonstration that this group was not involved in the metal-to-ligand 
bonds.
There are some modifications of the bands related to the CO stretchings of CO-aromatic ring and 
CO-CH3 moieties in the 1300-1200 cm-1 range, of the ternary complexes, both with respect to HSDM and 
AgSDM. The SCN and phen groups might interact with the SDM ligand by H-bonding. 
It has been reported that the structures of silver sulfonamides were found to depend highly on the 
substituent at the amide nitrogen of the sulfonamide. Silver is coordinated to that nitrogen and the 
sulfonamide remained in the amido form if no substituent is present or if the substituent is a phenyl, 
acetyl, or 2-pyrimidyl group. If the substituent is a 2-thiazolyl or 2-pyridinyl group, the sulfonamide is in 
the imido form and silver coordinates to the nitrogen of the substituent [28]. In the present case, the 
substituent is 2,6-dimethoxy-4-pyrimidine and it can be deduced from the vibrational analysis that silver 
interacted with the nitrogen atom of the aromatic ring, generating changes in the methoxy groups 
vibrations. Besides, it is difficult to determine whether the N atom of the sulfonamide group remained in 
the anionic form or interacted with the other Ag(I) cation present in the complexes. In the AgSDM-SCN 
complex, the thiocyanate ion can coordinate to the metal through either the nitrogen or the sulphur atom. 
These two different modes of coordination are easily distinguishable by the infrared absorption 
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frequencies of the thiocyanate radical. The free thiocyanate ion absorbs at about 750 and 2055 cm-1 (C-S 
and C-N stretching vibrations respectively); these peaks are shifted to 780-860 and 2080-2095 cm-1 
respectively in the SCN-metal complex and 690-720 and 2100-2125 cm-l respectively in the NCS-metal 
complex [29]. The thiocyanate group in the complex AgSDM-SCN absorbed at 754 cm-1 and 2086 cm-1 
(as a single band), as would be expected if coordination occurred through the nitrogen atom of the 
thiocyanate ligand, hence discarding possible S- and bridging coordinations.
The spectra of the ternary complexes themselves differed in minor respects. These differences 
corresponded to the silver coordination to SCN- or phenanthroline ligands. While the AgSDM-SCN 
complex displayed the typical vibrational modes assigned to the SCN group, the AgSDM-phen complex 
showed the main differences in the 700-900 cm-1 region. The C-H deformation bands of phenanthroline 
around 852 cm-1 and 738 cm-1 moved to lower frequency 841 cm-1 and 721 cm-1 in the complex. This red 
shift is indicative of the coordination of the ligand to the metal center [30].  
3.3. 1H and  13C NMR spectra
1H NMR spectra of the synthesized compounds and free ligands were collected and analyzed. 
Chemical shifts (δ) are in ppm relative to the residual DMSO-d6 signals. Assignment of H are showed in 
Fig. 3.
AgSDM: B 7.5757 (d, 2H, 3J = 8.55 Hz); C 6.5690 (d, 2H, 3J = 8.76 Hz); D 5.9990 (s, 3H); E 
5.8270 (s, 1H); F 3.8895 (s, 3H); G 3.8245 (s, 3H).
AgSDM-SCN: B 7.5628 (d, 2H, 3J = 8.40 Hz); C 6.5560 (d, 2H, 3J = 8.67 Hz); D 5.9860 (s, 
3H); E 5.8140 (s, 1H); F 3.8891 (s, 3H); G 3.8163 (s, 3H).
AgSDM-phen: B 7.5814 (d, 2H, 3J = 8.41 Hz); C 6.5667 (d, 2H, 3J = 8.55 Hz); D 6.0260 (s, 
3H); E 5.8191 (s, 1H); F 3.8809 (s, 3H); G 3.8175 (s, 3H); H 8.0657 (d, 2H, 3J = 8.37 Hz); I 7.8697 
(dd, 2H, 3J = 6.81Hz, 3J = 13.6 Hz); J 8.6061 (d, 2H, 3J = 7.44Hz); K  9.0464 (s, 2H).
1H and 13C NMR chemical shifts data from the spectra of HDSM, its sodium salt (NaSDM) and its 
silver complexes, in DMSO-d6, are showed in Tables 2 and 3. The 13C NMR spectrum of AgSDM-phen 
could not be taken due to the poor solubility of this compound in DMSO. Assignment of C are showed in 
Fig. 3.
Individual spectra (HSDM, NaSDM, its silver complexes, in addition to phen and its silver 
complex, and comparison of spectra in selected areas, as well as the figure of 
 ppm   compound  HSDM versus type of the sulfonamide hydrogen or carbon atoms are shown as 
supplementary material (Fig. S3-S5).
Table 2. 1H NMR data for HSDM, its sodium salt (NaSDM) and its silver(I) complexes: AgSDM, 
AgSDM-SCN, AgSDM-phen and the chemical shift differences with respect to the HSDM ones
HSDM NaSDM AgSDM AgSDM-SCN AgSDM-phen
H         
A 11.0924 --- --- --- --- --- --- --- ---
B 7.5529 7.3635 -0.1894 7.5757 0.0228 7.5628 0.0099 7.5814 0.0285
C 6.5865 6.4693 -0.1172 6.5690 -0.0175 6.5560 -0.0305 6.5667 -0.0198
D 6.0847 5.5553 -0.5294 5.9990 -0.0857 5.9860 -0.0987 6.0260 -0.0587
E 5.9302 5.3896 -0.5406 5.8270 -0.1032 5.8140 -0.1162 5.8191 -0.1111
F 3.7890 3.8794 0.0904 3.8895 0.1005 3.8821 0.0931 3.8809 0.0919
G 3.7811 3.8659 0.0848 3.8245 0.0434 3.8163 0.0352 3.8175 0.0364
Chemical shifts (δ) are in ppm relative to the residual DMSO-d6 signal (2.50  ppm).  ppm   compound  HSDM
: 
9
Table 3. 13C NMR data (ppm) for HSDM, its sodium salt (NaSDM) and its silver(I) complexes: 
AgSDM, AgSDM-SCN, and the chemical shift differences with respect to the HSDM ones
HSDM NaSDM AgSDM AgSDM-SCN
C       
1 171.5745 170.9987 -0.5758 171.8642 0.2897 171.8642 0.2897
2 164.3478 160.0075 -4.3403 164.9177 0.5699 164.9101 0.5623
3 160.146 155.9647 -4.1813 163.7613 3.6153 163.7919 3.6459
4 153.3222 150.5730 -2.7492 152.6026 -0.7196 152.6179 -0.7043
5 129.3122 133.2490 3.9368 129.3508 0.0386 129.3508 0.0386
6 124.1074 128.2479 4.1405 127.1757 3.0683 127.1680 3.0606
7 112.4025 112.5859 0.1834 113.0224 0.6199 113.0607 0.6582
8 84.1749 85.4205 1.2456 85.6809 1.506 85.7345 1.5596
9 54.3757 53.6369 -0.7388 55.4061 1.0304 55.3984 1.0227
10 53.6649 53.0089 -0.656 54.5253 0.8604 54.5253 0.8604





























Fig. 3 (a) H labels are indicated for HSDM and phen. (b) C labels are indicated for HSDM
1H NMR spectra: the signal of the amide proton [H(A),  =11.08 ppm in HSDM] is absent in the 
1H NMR spectra of NaSDM and the complexes, which indicates that the sulfa moiety is deprotonated in 
the complexes [11,12]. The most significant shifts are observed, in the three complexes, with proton “E” 
(shielded) and the protons of the methoxy groups (deshielded). From these, the most affected were the H 
atoms of the methoxy group labeled as “F”. 
13C NMR spectra for the assayed silver complexes, the most significant shifts are observed for 
carbon 6 and those atoms from the pyrimidine ring (C3, C8) and those of the methoxy groups (C9 and 
C10).
The IR and NMR spectra of the heteroleptic complexes differ very little from each other in 
relation to the sulfonamide moiety, being similar to the homoleptic one, therefore it could be suggested 
that the coordination points of the silver cation with the sulfonamide would be the same in the three 
complexes.
Silver in the +1 oxidation state has been found to adopt a wide variety of coordination geometries 
[31]. Other factors also showed influence in coordinating the Ag(I) ion, such as the nature and/or the 
stoichiometry of the ligands [32]. In the AgSDM complex, in the solid state, silver coordinates with the 
N-sulfonamidic atom, deprotonated, and with the pyrimidine N atom adjacent to the C atom named as 3 
[7-9]. This complex also shows an argentophilic interaction, similarly to another silver complexes with 
sulfonamides [8,11,12]. According to the FTIR spectrum of the AgSDM-SCN complex, the thiocyanate 
group would be coordinating with silver through the N atom of the SCN group. Some Ag(I) ternary 
complexes where one of the ligands is phen are curious because of the two different environments that 
surround the metal centers [10,33-35]. Among these, the heteroleptic silver(I) complex withN-(6-methyl-
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2-pyridyl)mesitylenesulfonamide (HMs6mepy) and phen, [Ag2(Ms6mepy)2phen], shows two different 
geometries around the metal, distorted {AgN2} digonal and {AgN4} tetrahedral, showing a 
supramolecular structure organized by π,π-stacking and C−H···O interactions [36]. A similar structure 
could be suggested for the complex [Ag2(SDM)2phen]·H2O. Fig. 4 represents, in a tentative and 































































Fig. 4. Schematic form of the minimum formulas of the complexes and a possible coordination of silver 
in each one: (a) AgSDM [7,8];  (b) AgSDM-SCN;  (c) AgSDM-phen
3.4. Lipophilicity test
With the aim of determining the lipophilic character of the silver complexes, which can be 
correlated with biological behavior properties like permeability through lipophilic barriers, partition 
coefficients (K) between n-octanol and water were determined. Log Koctanol/water values (log P) were 0.85, 
0.94 and 0.43 for AgSDM, AgSDM-SCN and AgSDM-phen respectively, which are close to the log P of 
the sulfonamide: 0.80 for HSDM and 0.84 for NaSDM. These values are similar to those of other sulfa-
metal complexes [11,37]. The heteroleptic complex AgSDM-phen showed a low log P value, although 
the value of phen is 1.78 [38]. We have observed a fact like this in our laboratory for the Ag(I) complex 
with sulfamerazine (HSMR) and phen: [Ag(SMR)phen] [39]. Also with the homo and heteroleptic 
complexes of silver(I) with albendazole, KSCN and phen [10] we have observed similar behavior, since, 
although albendazole has a Log P = 3.5 [40], which indicates high affinity for animal fatty tissues [41], 
the Log P of the complexes were in the range from 0.8 to 1.5 [42], which means from very low to low 
affinity for animal fatty tissues [41],. This behavior would be probably related to the distribution of polar 
residues in the compounds after complexation.
The values of the partition coefficient of the complexes of this work indicated a low affinity 
towards the animal fatty tissues [41], in a similar way to the free sulfonamide and its sodium salt. 
Although these values were lower than the values considered the optimal partition coefficient for 
permeating lipophilic membranes [43], this kind of complexes, such as silver sulfadiazine, is generally 
used topically for prevention and treatment of skin infections [44], so it may be convenient that they do 
not easily cross lipophilic barriers and remain at the site of the injury.
3.5. Antifungal properties
Results of the antifungal assays of sulfadimethoxine and its silver complexes are shown in Table 4 
and Fig S6. Examples of some Ag(I)-sulfonamide complexes were included for comparative purposes. In 
all cases, both silver–sulfadimethoxine complexes showed better antifungal activity than the free ligand, 
NaSDM, which, like other sulfonamides, was inactive against the tested fungi [11,12,45,46]. The assayed 
silver–sulfa complexes displayed a moderate activity against the tested fungi. It is important to note the 
activity against C. neoformans, a fact that could be of interest considering that  C. neoformans has 
become a major opportunistic fungal pathogen worldwide, whose incidence has considerably increased 
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for both the immune deficient [47] and the immune competent patients [48], and its resistance to 
antifungal drugs is high [49]. AgSDM-SCN showed better activity than its analogs against the 
dermatophytes assayed (Table 4). Silver(I), as AgNO3, showed lower MIC values than the complexes. 
However, the silver complexes have the advantage of a slow release of silver cation, preventing the 
inactivation [50] and the cytotoxicity of the free Ag(I) ions [51]. Anyway, it is important to have a drug 




Table 4.  MIC/ MFC values in µg/mL of sulfadimethoxine (as sodium salt: NaSDM), its silver(I) complexes: Ag-SDM, Ag-SDM-SCN, Ag-SDM-phen, and, for 
comparative purposes, MICs of AgNO3, AgSCN, phen, Ag-phen and selected sulfonamide-silver complexes acting against human opportunistic pathogenic fungi
Na SDM AgSDM AgSDM-SCN AgSDM-phen AgNO3(1)
AgSCN   
(2)










Ca. >250 31.25/62.5 15.6/62.5 15.6/31.25 6.36/12.72 31.25/62.5 31.25/125.0 62.5/125.0 31.25/125.0 31.25/>250 0.78 6.25 1.56
Ct. >250 62.5/62.5 15.6/31.25 31.25/62.5 12.72/25.44 31.25/62.5 31.25/125.0 62.5/125.0 31.25/125.0 31.25/>250 1.56 6.25 0.78
Cn. >250 15.6/62.5 15.6/31.25 15.6/ 31.25 3.18/12.72 15.60/62.5 15.6 /31.25 15.6 /125.0 31.25/62.5 15.6/125.0 0.78 1.56 0.39
Aspergillus
Afl. >250 62.5/250.0 62.5/125.0 31.25/125.0 12.72/12.72 31.25/125 31.25/125.0 31.25/125.0 31.25/ >250 31.25/125.0 0.78 6.25 0.78
Afu. >250 125.0/>250 62.5/250.0 31.25/125.0 25.44/25.44 31.25 62.5 31.25/62.5 31.25/125.0 31.25/ >250 31.25/62.5 3.12 12.5 0.78
Ani. >250 250.0/>250 125.0/ >250 31.25/125.0 25.44/25.44 31.25/125 62.5/125.0 31.25/125.0 31.25/ >250 62.5/125.0 0.78 6.25 1.56
Dermatophytes
Mg. >250 62.5/62.5 31.25/31.25 >250 12.72/12.72 62.5/62.5 62.5/125.0 125.0/125.0 125.0/125.0 >250 6.25 12.5 0.006
Tr. >250 62.5/62.5 31.25/62.5 >250 6.36/6.36 62.5/62.5 62.5/62.5 62.5/125.0 62.5/62.5 125.0/250 6.25 12.5 0.003
Tm. >250 62.5/125.0 31.25/31.25 >250 12.72/12.72 62.5/62.5 62.5/62.5 62.5/125.0 62.5/62.5 250/ >250 6.25 12.5 0.006
Ca.: C. albicans ATCC 10231; Ct.: C. tropicalisC 131; Cn.: C. neoformans ATCC 32264; Afl.: A. flavus ATCC 9170; Afu.: A. fumigatus ATCC 26934; Ani.: A. niger ATCC 9029; Mg.: M. 
gypseum C 115; Tr.: T. rubrum C 113; Tm.: T. mentagrophytes ATCC 9972   SCP: sulfachloropyridazine; SMX: sulfamoxole. MIC: Minimal Inhibitory Concentration; MFC: Minimal Fungicidal 
Concentration; Amp: Amphotericin B; Ket: Ketoconazole; Terb, Terbinafine (MIC´s in µg/mL). ATCC: American Type Culture Collection (Rockville, MD, USA); C: CEREMIC, Centro de 
Referencia Micológica, Facultad de Ciencias Bioquímicas y Farmacéuticas, Suipacha 531-(2000)-Rosario, Argentina.Remarkable results fort hecomplexes are in bold. (1): [58]; (2): [12]; (3): [11]
: 
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3.6. Plant Genotoxicity Test (Allium cepa Test)
The A. cepa test, which is considered an efficient tool to evaluate toxic effects of different 
chemicals, currently in use [3] was selected to assess the potential cytogenotoxic effects of the 
evaluated silver-sulfadimethoxine complexes. A .cepa test has a long history in scientific literature 
i.e. developed and described by Levan [53], later modified for environmental monitoring [54] and 
optimization of the technique [55]. A. cepa species have been frequently used to determine the 
cytotoxic and genotoxic effects of several substances, being considered a standard organism for 
quick tests, since it shows a high correlation with mammal test systems [3 d)], although it cannot 
replace other studies such as mammalian cell cultures. Another advantage of this test system is the 
presence of an oxidase enzyme system, which is useful for promutagen evaluations [56], fact that 
we checked in our laboratory with the promutagen 2-aminofluorene [57]. The results of 
phytotoxicity (as change of root length –RL–, expressed as % from the RL of the negative control) 
and cytotoxicity, expressed as the cytotoxic index (CI) calculated as: MI‰ of the sample/MI‰ of 
the negative control, of NaSDM and its silver complexes, evaluated with the A. cepa test are shown 
in Tables 5 and 6, and Fig. 4 (supplementary material Fig. S8).
Table 5. Phytotoxicity (as % of the change of root length, RL, respect to the negative control: Δ± 
SD) of sodium sulfadimethoxine (NaSDM) and its silver(I) complexes, evaluated with the A. cepa 
test







AgSDM- SCN;   
251.6 mg.L-1
AgSDM-phen;   
258.6 mg.L-1
0 (b)  (2.91± 0.76) cm;  % RL: 100.0 ± 25.94 (2.10 ± 0.39) cm;     
% RL: 100.0 ± 18.56
1/20 100.1 ± 14.62 65.77 ± 33.79 54.90 ± 27.79 65.08 ± 52.24
1/4 99.51 ± 37.51 41.75 ± 12.91 21.73 ± 15.14 14.29 ± 7.78
1/2 85.78 ± 23.07 21.96 ± 9.89 28.02 ± 22.49 19.64 ± 9.20
3/4 67.48 ± 25.83 11.44 ± 9.12 10.87 ± 12.16 21.43 ± 22.16
1 92.65 ± 15.19 8.58 ± 14.19 15.44 ± 14.84 8.33 ± 8.13
Linear 
Regression (c)  
y = 98.52 – 0.050x
r: -0.53; p: 0.28
y = 62.24 – 0.257x
r: -0.87; p: 0.022
y= 53.44 – 0.195x
r:-0.71 p: 0.12  (d)
y = 25.26 –0.065x
r: -0.46; p: 0.36  (d)
: [RL substance (mean, cm)/RL negative control, mean, cm]100; SD: standard deviation.r: Pearson's correlation 
coefficient. (a): dilution from mother solution. (b): negative control (mineral water). (c):  y = a + bx; weight given by 
data sd error bars. p-value ≤ 0.05 was considered as statistically significant [20]. (d):  Mean significantly different from 
the negative control mean (Student's t-test post ANOVA at the 0.05 level)
Table 6. Cytotoxic Index (C.I.) for sodium sulfadimethoxine (NaSDM) and its silver(I) complexes, 
evaluated with the A.cepa test







AgSDM-SCN;   
251.6 mg.L-1
Ag-SDM-phen;          
258.6mg.L-1
0 (b)  C. I.: 1.0 ± 0.21 (M.I.: 27.5 ± 5.86) C.I.: 1.0 ± 0.15  (M.I.: 30.6 ± 4.67)
1/20 1.14 ± 0.15 1.76 ± 0.28 1.31 ± 0.23 0.97± 0.50
1/4 0.94 ± 0.18 0.99 ± 0.26 1.18 ± 0.17
1/2 1.11 ± 0.05 1.00 ± 0.26 1.26 ± 0.13
3/4 1.15 ± 0.28 0.81 ± 0.17 0.74 ± 0.16





y = 1.05 + 3.82E-4x
r: 0.37; p: 0.47
y = 1.23 – 0.0018x
r: -0.56; p: 0.25
y = 1.23 – 0.00115x
r: -0.40; p: 0.44
it was not possible to analyze 
statistically
C.I.: MI sample/MI negative control; MI mitotic index: Nº dividing cells/1000 cells.  r: Pearson's correlation coefficient; 
(a) dilution from mother solution; (b): negative control (mineral water); (c):  y = a + bx; weight given by data sd error 
















































Fig. 5. Influence of the concentration of NaSDM and its silver complexes (a) on the root elongation and (b) 
on the cytotoxic index (Mitotic index of the sample/mitotic index of negative control) of A. cepa L. 
Phytotoxicity: The analysis by linear regression and/or the Student´s t-test performed post ANOVA 
showed significant influence of the concentration of the silver complexes on the change of root 
length of A. cepa L. We have observed similar influence of AgNO3 (in distilled water) in a range of 
up to 200 mg.L-1 [58]. On the other hand, we did not observe any influence of NaSDM and DMSO 
(Fig. S3) with respect to the negative control (mineral water). 
Mitotic index (MI): Inhibition of mitotic activities is often used for tracking cytotoxic substances. A 
MI decrease below 22% of the control causes lethal effects on test organisms, while a decrease 
below 50% (cytotoxic limit value) usually has sub-lethal effects [59]. Moreover, the inhibition of 
division without the observation of chromosome aberrations may be a promising result for 
anticancer therapy, as it leads first to block the development of cancer [60]. NaSDM and the 
complexes AgSDM and AgSDM-SCN did not modify the MI in the range of experimented 
concentrations. On the contrary, the AgSDM-phen complex showed significant inhibition of the MI, 
probably due to the phenanthroline moiety of the compound [61]. Similar behavior presented other 
silver complexes with phenanthroline derivatives, also with antifungal properties, which they 
showed anticancer properties [62].
4. Conclusion
Fungal infections are still a big problem. Two new heteroleptic synthesized complexes 
between sodium sulfadimethoxine (NaSDM) and the silver(I) ion: AgSDM-SCN and AgSDM-
phen, and the homoleptic one, AgSDM, showed moderate antifungal activity (NaSDM was 
inactive), low affinity towards animal fatty tissues and no genotoxicity or cytotoxicity in the A. cepa 
test, except AgSDM-phen. Given these results, the analyzed complexes might be good candidates 
for further pharmaceutical studies.
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Fig. 1. Sulfadimethoxine (HSDM), IUPAC name: 4-Amino-N-(2,6-dimethoxypyrimidin-4-
yl)benzenesulfonamide; formula:  C12H14N4O4S, MW: 310.33 g.mol-1
Fig.2. FTIR spectra of sulfadimethoxine (HSDM), its sodium salt (NaSDM) and its Ag(I) complexes 
(AgSDM, AgSDM–SCN and AgSDM–phen) in the wavenumber range of 4000-400 cm-1
Fig. 3 (a) H labels are indicated for HSDM and phen. (b) C labels are indicated for HSDM
Fig. 4. Schematic form of the minimum formulas of the complexes and a possible coordination of 
silver in each one: a) AgSDM [7,8]; b) AgSDM-SCN; c) AgSDM-phen
Fig. 5. Influence of the concentration of NaSDM and its silver complexes (a) on the root elongation and (b) 














1) Two new silver-sulfadimethoxine complexes were synthesized.
2) Coordination of silver ions occurs through amide and heterocyclic nitrogens.


















y = -0.03 +0.067 x































































Fungal infections are still a big problem. Two new heteroleptic complexes between sodium 
sulfadimethoxine (NaSDM) and the silver(I) ion: AgSDM-SCN and AgSDM-phen, and AgSDM, 
showed moderate antifungal activity (sulfadimethoxine was inactive), low affinity towards animal 
fatty tissues and no geno or cytotoxicity in the Allium cepa test, except AgSDM-phen, so, these 
complexes could be good candidates for further pharmaceutical studies.
